ACET Shares Outstanding History



Below is a table of the ACET shares outstanding history going back to 2/2/2010:

Date ACET Shares Outstanding
2/2/20103.61M
5/3/20103.63M
9/3/20103.63M
11/2/20103.64M
2/1/20113.80M
5/2/20113.80M
9/2/20113.81M
11/1/20113.82M
2/3/20123.83M
5/1/20123.83M
9/4/20123.87M
11/6/20123.88M
2/4/20133.90M
5/6/20133.91M
8/23/20134.01M
11/1/20134.02M
2/3/20144.05M
5/5/20144.10M
9/2/20144.14M
11/3/20144.15M
2/2/20154.16M
5/4/20154.16M
9/8/20154.19M
11/2/20154.21M
2/1/20164.22M
5/2/20164.23M
8/22/20164.24M
11/1/20164.29M
2/1/20174.30M
5/1/20174.30M
8/21/20174.30M
10/31/20174.38M
1/30/20184.39M
5/1/20184.40M
9/13/20184.40M
10/15/20184.40M
11/5/20184.40M
2/12/20194.41M
9/16/202019.59M
11/3/202019.60M
3/10/202131.78M
5/12/202131.81M
8/10/202131.84M
11/9/202131.96M
3/10/202239.88M
5/9/202240.00M
8/5/202240.03M
11/4/202242.85M
3/10/202342.95M
5/5/202342.96M
8/7/202343.07M
11/6/202343.16M
3/14/202482.15M
5/10/202482.17M
8/9/202482.40M

Also see: ACET Market Cap History
ACET YTD Return
ACET Historical Shares Outstanding:
+24.03% CAGR
ACET Historical Shares Outstanding: +24.03% CAGR

Mouse over chart for data details
2/2/2010 ...8/9/2024
Adicet Bio, Inc. is a clinical stage biotechnology company. Co. is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma (NHL). We show 55 historical shares outstanding datapoints in our coverage of ACET's shares outstanding history.

Understanding the changing numbers of ACET shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACET versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACET by allowing them to research ACET shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ACET Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aceto (ACET) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ACGN Shares Outstanding History
ACHC Shares Outstanding History
ACHN Shares Outstanding History
ACHV Shares Outstanding History
ACLX Shares Outstanding History
ACON Shares Outstanding History
ACOR Shares Outstanding History
ACRS Shares Outstanding History
ACRV Shares Outstanding History
ACRX Shares Outstanding History
More Healthcare companies »

 

ACET Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.